(Q37815628)

23 August 2017

1 reference

title

The continuing crisis in antibiotic resistance (English)

1 reference

23 August 2017

antibiotic resistance

1 reference

G L French

1

1 reference

PubMed ID

21129629

23 August 2017

language of work or name

1 reference

1 November 2010

1 reference

International Journal of Antimicrobial Agents

23 August 2017

1 reference

23 August 2017

36 Suppl 3

1 reference

23 August 2017

S3-7

1 reference

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Occurrence of serious bacterial infections since introduction of antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Antibiotic-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

The emergence and evolution of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

VanA-type vancomycin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Guidelines for the control of glycopeptide-resistant enterococci in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Resistance to glycopeptides in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Historical yearly usage of vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

National Clostridium difficile Standards Group: Report to the Department of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Clinical impact and relevance of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

The crisis in antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Resistance to antimicrobial drugs--a worldwide calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Epidemiology of drug resistance: implications for a post-antimicrobial era

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

Trends in antimicrobial drug development: implications for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2810%2970003-0

7 January 2021

10.1016/S0924-8579(10)70003-0

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21129629